Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $25.70. The company's market cap stands at 146.48B, with a P/E ratio of 19.43 and a dividend yield of 6.8%.
On 2026-06-04, Pfizer(PFE) stock moved within a range of $25.50 to $26.01. With shares now at $25.70, the stock is trading +0.8% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 30.93M, compared to an average daily volume of 31.79M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.08.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $23.08.
PFE News
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Astellas Pharma (ALPMF), Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premiu...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Analyst ratings
55%
of 29 ratingsMore PFE News
Key Points Pfizer has a higher forward dividend yield than Bristol Myers Squibb, but the latter beats the former in most other criteria. Bristol Myers Squibb...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings a...
Pfizer vs Merck: Chasing High Yield vs Higher Returns By Vandita Jadeja Published Jun 3, 10:06AM EDT Quick Read PFE yields 6.58% at a forward P/E of 9, while...
Over the past few years, Bristol Myers Squibb (BMY 1.09%) and Pfizer (PFE 0.29%), have underperformed broader equities. However, throughout it all, they have ma...
Why Pfizer’s Current Price May Be Too Cheap to Ignore By Vandita Jadeja Published Jun 2, 10:03AM EDT Quick Read Pfizer (PFE) trades at $26.18 with a 24/7 Wall...
Pfizer reported new seven-year data from the Phase 3 CROWN trial at ASCO 2026, highlighting LORBRENA for untreated ALK-positive advanced non small cell lung can...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.